Essex Woodlands Management, Inc. — 13F Holdings & Portfolio
CIK 1542339 · latest 13F-HR filed 2026-05-04
Essex Woodlands Management, Inc. manages $250.5M in 13F-reported U.S. long-equity assets across 5 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are BVS (47.45%), MDXG (44.45%), EYPT (5.58%). Quarter over quarter (versus its 2025-12-31 filing) the fund opened 0 new positions, exited 1, added to 1, and trimmed 3.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$250.5M
Long-equity book
5
Distinct positions
2026-03-31
Filed 2026-05-04
+0 / −1 / ↑1 / ↓3
vs 2025-12-31
| Name | Title / Status | Ownership | Type |
|---|
Top Trims
- MIMEDX GROUP INC-$79.5M -41.7%
- EYEPOINT PHARMACEUTICALS INC-$5.8M -29.4%
- TELA BIO INC-$4.3M -47.5%
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | BIOVENTUS INC | BVS | 09075A108 | $118.9M | 47.45% | 13,021,324 | SH |
| 2 | MIMEDX GROUP INC | MDXG | 602496101 | $111.4M | 44.45% | 28,195,249 | SH |
| 3 | EYEPOINT PHARMACEUTICALS INC | EYPT | 30233G209 | $14.0M | 5.58% | 1,084,857 | SH |
| 4 | TELA BIO INC | TELA | 872381108 | $4.8M | 1.91% | 7,714,709 | SH |
| 5 | MEDICINOVA INC | MNOV | 58468P206 | $1.5M | 0.60% | 1,105,941 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-03-31 | 2026-05-04 | $250.5M | 5 | 0000908834-26-000206 |
| 2025-12-31 | 2026-02-04 | $318.3M | 6 | 0000908834-26-000038 |